Refine Search
(0)
(0)
(4)
(4)

Digestive Cancers

GlobalData’s coverage of the digestive cancers space includes an in-depth market analysis, drug sales forecast and epidemiological analysis. In addition, the reports provide top-line epidemiology, pipeline, clinical and commercial assessments, R&D strategies, as well as enrollment analytics and a 10-year landscape with anticipated key clinical, regulatory and commercial events. This series of reports provides both expert- and data-driven insight on the current and future treatment landscape, key unmet needs, and opportunities to compete in the market for digestive cancers.

Pancreatic Cancer: Opportunity Analysis and Forecast to 2026

  • $10,995
  • April 2018
Add to Basket Quick View Add to Saved List

Pancreatic cancer is set to become the second leading cause of cancer-related deaths in the US in 2020 after lung cancer, despite accounting for only 3% of new cancer diagnoses. Patients with advanced pancreatic cancer have a median survival of...

Pancreatic Cancer: Epidemiology Forecast to 2026

  • $3,995
  • April 2018
Add to Basket Quick View Add to Saved List

Pancreatic cancer is one of the most fatal cancers around the world, with the highest incidence and mortality rates found in developed countries (Michaud, 2004). Rarely, cancer can form in the hormone-producing cells or the neuroendocrine cells...

Colorectal Cancer: Competitive Landscape to 2026

  • $3,495
  • April 2018
Add to Basket Quick View Add to Saved List

Colorectal cancer (CRC) is a cancer that originates in either the colon or the rectum. CRC is the fourth leading cause of mortality among cancer patients in the world, and is the third most diagnosed cancer globally. Most cases of CRC present a...

Gastric and Gastroesophageal Junction Adenocarcinoma (G/GEJAC): Competitive Landscape to 2026

  • $3,495
  • February 2018
Add to Basket Quick View Add to Saved List

Gastric and gastroesophageal junction adenocarcinoma (G/GEJAC) represents the majority of gastric cancer cases worldwide. It is the fifth most diagnosed cancer globally, and the third most common cause of cancer death in the world. This report ...